In this study, we aimed to investigate the role of m6A modification in TEX across multiple cancer types by focusing on the crosstalk between m6A regulators and key TEX-related genes, and exploring how this interaction influences TEX, survival outcomes, and responses to immunotherapy. This evidence concerns the gene TEX46 and cancer.